Provided by Tiger Trade Technology Pte. Ltd.

GeoVax Labs Inc

0.7210
+0.00400.56%
Post-market: 0.6400-0.0810-11.23%19:58 EDT
Volume:744.47K
Turnover:494.92K
Market Cap:5.31M
PE:-0.26
High:0.7274
Open:0.6972
Low:0.6800
Close:0.7170
52wk High:19.21
52wk Low:0.5900
Shares:7.37M
Float Shares:7.37M
Volume Ratio:0.48
T/O Rate:10.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7720
EPS(LYR):-120.4555
ROE:-891.59%
ROA:-256.80%
PB:3.02
PE(LYR):-0.01

Loading ...

GeoVax Faces NASDAQ Delisting After Shares Stay Below $1 Bid Price Threshold

Reuters
·
Aug 29

GeoVax Labs Secures Immediate Exercise of 5,697,628 Stock Warrants at USD 0.64

Reuters
·
Aug 29

Analysts’ Opinions Are Mixed on These Healthcare Stocks: GeoVax Labs (GOVX), Incyte (INCY) and Altimmune (ALT)

TIPRANKS
·
Jul 29

GeoVax Labs Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 28

Geovax Labs Q2 EPS $(0.97) Beats $(2.88) Estimate

Benzinga Earnings
·
Jul 28

GeoVax Labs - Q2 2026 Net Loss $4.43 Mln, or $0.97 Per Share - SEC Filing

THOMSON REUTERS
·
Jul 28

GeoVax Q2 FY26 Net Loss Narrows to $4.43 Million, or $0.97 a Share; Revenue Posts no Revenue

Reuters
·
Jul 28

Geovax Labs Inc Expected to Post a Loss of $2.88 a Share - Earnings Preview

Reuters
·
Jul 25

Geovax Gets NASDAQ Notice for Failing $2.5 Million Stockholders’ Equity Requirement

Reuters
·
Jul 11

GeoVax Labs shareholders approve Wipfli as independent auditor for 2026

Reuters
·
Jun 18

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), GeoVax Labs (GOVX) and Vir Biotechnology (VIR)

TIPRANKS
·
May 27

GeoVax Labs discontinues development of COVID-19 vaccine candidate

TIPRANKS
·
May 27

Roth Capital ‘strongly’ agrees with GeoVax ending COVID-19 development

TIPRANKS
·
May 27

GeoVax Labs files to sell 7.64M shares of common stock for holders

TIPRANKS
·
May 26

GeoVax prices USD 3 million private placement at-the-market under Nasdaq rules

Reuters
·
May 20

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:03 AM

Reuters
·
May 18

Geovax Labs Q1 EPS $(2.62) Beats $(4.42) Estimate

Benzinga Earnings
·
May 15

GeoVax net loss narrows 1.79% to $5.26 million in Q1 FY26

Reuters
·
May 15

GeoVax enters warrant inducement for exercise of 501,144 existing warrants

Reuters
·
May 08

GeoVax Labs Inc expected to post a loss of $4.42 a share - Earnings Preview

Reuters
·
Apr 28